Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vibrio cholerae O1 Inaba O-specific polysaccharide (OSP) is a critical surface component of the lipopolysaccharide (LPS) found in the Inaba serotype of Vibrio cholerae O1, the primary causative agent of epidemic cholera [1]. Structurally, it is a homopolymer of alpha(1-2)-linked 4-amino-4,6-dideoxy-D-mannose (D-perosamine) units, which are N-acylated with 3-deoxy-L-glycero-tetronic acid [2]. The Inaba serotype is distinguished from the Ogawa serotype by the absence of a 2-O-methyl group on the non-reducing terminal perosamine residue [2,3]. Biologically, the OSP is essential for maintaining the structural integrity of the bacterial outer membrane and serves as the dominant target for the host's protective immune response [1,4]. Antibodies directed against the OSP, particularly vibriocidal antibodies, are strongly correlated with protection against infection and are the primary mechanism by which oral cholera vaccines (OCVs) confer immunity [3,5]. Consequently, OSP is a central component in the formulation of killed whole-cell vaccines and is a major focus for the development of next-generation conjugate vaccines aimed at providing long-term mucosal protection [4,6]. Sources: [1] Chatterjee & Chaudhuri (2003) Biochim Biophys Acta; [2] Villeneuve et al. (2000) PNAS; [3] WHO (2017) Cholera vaccines: WHO position paper; [4] Grandy et al. (2021) Front Immunol; [5] Harris et al. (2012) Lancet; [6] Xu et al. (2011) Bioconjug Chem.
Induction of protective vibriocidal antibodies and mucosal IgA that inhibit bacterial colonization and promote pathogen clearance [3,5].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 Inaba O-specific polysaccharide antigen (OSP).